Robert E. Gagnon - Net Worth and Insider Trading

Robert E. Gagnon Net Worth

The estimated net worth of Robert E. Gagnon is at least $2 Million dollars as of 2024-04-28. Robert E. Gagnon is the CFO of Harvard Bioscience Inc and owns about 321,169 shares of Harvard Bioscience Inc (HBIO) stock worth over $1 Million. Robert E. Gagnon is the Vice President, Finance of Biogen Inc and owns about 3,999 shares of Biogen Inc (BIIB) stock worth over $835,391. Robert E. Gagnon is also the Director of Verastem Inc and owns about 27,391 shares of Verastem Inc (VSTM) stock worth over $256,928. Details can be seen in Robert E. Gagnon's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert E. Gagnon has not made any transactions after 2024-03-19 and currently still holds the listed stock(s).

Transaction Summary of Robert E. Gagnon

To

Robert E. Gagnon Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert E. Gagnon owns 4 companies in total, including Verastem Inc (VSTM) , Harvard Bioscience Inc (HBIO) , and Clean Harbors Inc (CLH) among others .

Click here to see the complete history of Robert E. Gagnon’s form 4 insider trades.

Insider Ownership Summary of Robert E. Gagnon

Ticker Comapny Transaction Date Type of Owner
VSTM Verastem Inc 2024-03-19 Chief Financial Officer
HBIO Harvard Bioscience Inc 2018-08-29 Chief Financial Officer
CLH Clean Harbors Inc 2012-08-20 EVP CFO and Treasurer
BIIB Biogen Inc 2012-02-29 Chief Acct Officer VP & Contol

Robert E. Gagnon Latest Holdings Summary

Robert E. Gagnon currently owns a total of 3 stocks. Among these stocks, Robert E. Gagnon owns 321,169 shares of Harvard Bioscience Inc (HBIO) as of August 29, 2018, with a value of $1 Million and a weighting of 51.56%. Robert E. Gagnon owns 3,999 shares of Biogen Inc (BIIB) as of February 29, 2012, with a value of $835,391 and a weighting of 37.05%. Robert E. Gagnon also owns 27,391 shares of Verastem Inc (VSTM) as of March 19, 2024, with a value of $256,928 and a weighting of 11.39%.

Latest Holdings of Robert E. Gagnon

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HBIO Harvard Bioscience Inc 2018-08-29 321,169 3.62 1,162,632
BIIB Biogen Inc 2012-02-29 3,999 208.90 835,391
VSTM Verastem Inc 2024-03-19 27,391 9.38 256,928

Holding Weightings of Robert E. Gagnon


Robert E. Gagnon Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 0 transactions in Harvard Bioscience Inc (HBIO) over the past 5 years. The most-recent trade in Harvard Bioscience Inc is the sale of 8,889 shares on August 29, 2018, which brought Robert E. Gagnon around $51,290.

According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 1,552 shares on February 29, 2012, which brought Robert E. Gagnon around $178,868.

According to the SEC Form 4 filings, Robert E. Gagnon has made a total of 12 transactions in Verastem Inc (VSTM) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Verastem Inc is the sale of 413 shares on March 19, 2024, which brought Robert E. Gagnon around $4,382.

Insider Trading History of Robert E. Gagnon

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert E. Gagnon Trading Performance

GuruFocus tracks the stock performance after each of Robert E. Gagnon's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E. Gagnon is 10.52%. GuruFocus also compares Robert E. Gagnon's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E. Gagnon within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert E. Gagnon's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert E. Gagnon

Average Return

25.74%

Average return per transaction

Outperforming Transactions

50%

2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.23 10.52 9.63 25.74 8.76 8.18
Relative Return to S&P 500(%) 6.53 12.68 7.08 14.14 -2.8 -2.14

Robert E. Gagnon Ownership Network

Ownership Network List of Robert E. Gagnon

No Data

Ownership Network Relation of Robert E. Gagnon


Robert E. Gagnon Owned Company Details

What does Verastem Inc do?

Who are the key executives at Verastem Inc?

Robert E. Gagnon is the Chief Financial Officer of Verastem Inc. Other key executives at Verastem Inc include Vice President of Finance Daniel Calkins , Chief Operating Officer Dan Paterson , and other: See Explanation of Responses Bvf I Gp Llc .

Verastem Inc (VSTM) Insider Trades Summary

Over the past 18 months, Robert E. Gagnon made 8 insider transaction in Verastem Inc (VSTM) with a net sale of 39,211. Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 2,240 shares made by Daniel Calkins , a net sale of 41,587 shares made by Brian M Stuglik , and a net sale of 25,810 shares made by Dan Paterson .

In summary, during the past 3 months, insiders sold 10,939 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 10,939 shares. During the past 18 months, 108,848 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 108,848 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Verastem Inc Insider Transactions

No Available Data

Robert E. Gagnon Mailing Address

Above is the net worth, insider trading, and ownership report for Robert E. Gagnon. You might contact Robert E. Gagnon via mailing address: C/o Biogen Idec Inc., 133 Boston Post Road, Weston Ma 02493.

Discussions on Robert E. Gagnon

No discussions yet.